Evidence map›Paper›PMID 29434151›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Diagnosed by Peripheral Facial Nerve Palsy.

Aya Imafuku, Kiho Tanaka, Yuji Marui, Yoshifumi Ubara, Kenmei Takaichi, Shinji Tomikawa, Yasunori Ota, Takeshi Fujii, Yasuo Ishii

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Aya ImafukuDepartment of Nephrology Center, Toranomon Hospital, Japan.
Kiho TanakaDepartment of Nephrology Center, Toranomon Hospital, Japan.
Yuji MaruiDepartment of Nephrology Center, Toranomon Hospital, Japan.
Yoshifumi UbaraDepartment of Nephrology Center, Toranomon Hospital, Japan.
Kenmei TakaichiDepartment of Nephrology Center, Toranomon Hospital, Japan.
Shinji TomikawaDepartment of Nephrology Center, Toranomon Hospital, Japan.
Yasunori OtaDepartment of Pathology, Toranomon Hospital, Japan.
Takeshi FujiiDepartment of Pathology, Toranomon Hospital, Japan.
Yasuo IshiiDepartment of Nephrology Center, Toranomon Hospital, Japan.
Toranomon Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although primary central nervous system post-transplant lymphoproliferative disorder (PCNS-PTLD) causes various symptoms depending on the tumor region, there has been no previous report of PCNS-PTLD in the cerebellopontine angle that was diagnosed due to peripheral facial nerve palsy. We herein report a case involving a 62-year-old man with PCNS-PTLD in the cerebellopontine angle who was diagnosed due to peripheral facial nerve palsy. The reduction of immunosuppressive therapy, whole-brain radiotherapy, intrathecal chemotherapy, and rituximab were effective in treating this patient. Physicians should therefore be mindful that PCNS-PTLD can cause peripheral facial nerve palsy in renal transplant recipients.

Indexed as

Cerebellopontine AngleFacial NerveFacial ParalysisHumansImmunosuppressive AgentsKidney TransplantationLymphoproliferative DisordersMaleMiddle AgedPhosphoproteinsRituximabImmunosuppressive AgentsPhosphoproteinsPSRC1 protein, humanRituximabcerebellopontine angle tumorperipheral facial nerve palsyprimary central nervous system post-transplant lymphoproliferative disorder

Identifiers

PMID29434151
PMCPMC6064700
OpenAlexW2786492285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.